As desperation grows to get unwilling people vaccinated, researchers find that the answer may very well lie in being more directly transparent with their clinical data. If people are welcomed to see the research and results surrounding the vaccines they are being asked to take, it may help to shift the tide. Transparency of this […]
Clinical Trials
Transparency Builds Trust: The Fight to Vaccinate the Unwilling
August 18th, 2021 | Clinical TrialsWith Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout
August 9th, 2021 | Clinical TrialsWhen Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite positive trial data, the FDA is demanding that there be more evidence of […]
Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
August 4th, 2021 | Clinical Trials
To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is comprised of a specialized group of experts, all of whom focus in a specific niche. The committee is centrally […]
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
July 27th, 2021 | Clinical Trials
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions between cells infected with SARS-CoV-2 and the human immune system. Studying these […]
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
July 21st, 2021 | Clinical TrialsAs the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions between cells infected with SARS-CoV-2 and the human immune system. Studying these […]
Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
July 15th, 2021 | Clinical TrialsTo help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is comprised of a specialized group of experts, all of whom focus in a specific niche. The committee is centrally involved with the gene […]
With Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout
July 8th, 2021 | Clinical Trials
When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite positive trial data, the FDA is demanding that there be more evidence of the drug’s effect […]
We are Hiring – Open Contractor Positions at MVG Consulting
February 8th, 2021 | Clinical TrialsLooking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!
COVID-19 Heightens Call for Diversity within Biopharma
January 26th, 2021 | Clinical Trials
COVID-19, and its disproportionate effect on minority populations highlighted the need for increased diversity in clinical trials in order to adequately treat every patient population. The biopharma industry has resisted diversification in the past because its infrastructure breeds success in working within non-diverse populations. However, 2020, changed things, and the urgency to improve diversification is […]
Decentralized Clinical Trials: Here Comes the Future
January 20th, 2021 | Clinical Trials
Once a seemingly far-fetched endeavor, decentralized clinical trials are gaining favor in the wake of COVID-19. It has become clear that the time for entirely in-person clinical trials has passed, paving the way for a new, technologically integrated approach. This next year will be exceptionally telling as telemedicine and mobile health tracking continue to drive […]